reports
Despite a better risk assessment and improving to Slightly Negative, C...
CELLTRION HEALTHCARE (KR), a company active in the Pharmaceuticals industry, improves its market behaviour and slightly increases its general evaluation. The independent financial analyst theScreener just upgraded the stock market behaviour as moderately risky. At a fundamental level, theScreener confirms 1 out of 4 possible stars; the general evaluation is slightly increased to Slightly Negative but the title remains under pressure. As of the analysis date February 22, 2022, the closing price w...
- Dave Nicoski
- Ross LaDuke
Vermilion Int'l Compass: Global Equity Strategy
Initial Low Established Several equity indexes and indicators we watch are telling us an initial primary low has been established for global equities (ACWI-US). At the same time, after this type of major waterfall decline there is often a test of this initial low - and oftentimes we get an undercut of the initial low. Barring approval of a first-line therapy for COVID-19 we are of the belief that we will get an eventual test of this initial low and potentially an undercut. Below we provide upda...
A0M368 BEIJING SHUNXIN AGRICULTURE CO. LTD. CLASS A
7595 ARGO GRAPHICS INC.
CSL CSL LIMITED
600252 GUANGXI WIZHOU ZHONGHENG GROUP CO. LTD. A
600378 HAOHUA CHEMICAL SCIENCE & TECHNOLOGY (A)
3038 EMERGING DISPLAY TECHNOLOGIES CORP.
002242 JOYOUNG COMPANY LIMITED CLASS A
002410 GLODON COMPANY LIMITED CLASS A
601100 JIANGSU HENGLI HYDRAULIC CO. LTD. CLASS A
002511 C&S PAPER CO. LTD. CLASS A
300070 BEIJING ORIGINWATER TECHNOLOGY CO. LTD. CLASS A
002568 SHANGHAI BAIRUN INVESTMENT HOLDING GROUP CO. LTD. CLASS A
ABX AUSTRALIAN BAUXITE LTD
002777 SICHUAN JIUYUAN YINHAI SOFTWARE (A)
6920 LASERTEC CORP.
600862 AVIC AVIATION HIGH-TECHNOLOGY CO. LTD. CLASS A
BANB BACHEM HOLDING AG CLASS B
TAL1T TALLINK GROUP
31V VINDA INTERNATIONAL HOLDINGS LIMITED
DPW DP WORLD PLC
DIMET DIMET (SIAM) PCL
300122 CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO. LTD. CLASS A
002311 GUANGDONG HAID GROUP CO. LIMITED CLASS A
002649 BEYONDSOFT (A)
PLUS PLUS500 LTD.
300369 NSFOCUS INFORMATION TECHNOLOGY (A)
002714 MUYUAN FOODS CO. LTD. CLASS A
SF STILLFRONT GROUP AB
ZTO ZTO EXPRESS (CAYMAN) INC. SPONSORED ADR CLASS A
ASML ASML HOLDING N.V.
GALE GALENICA AG
ZLAB ZAI LAB LTD. SPONSORED ADR
091990 CELLTRION HEALTHCARE CO. LTD.
300601 SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO. LTD. CLASS A
300630 HAINAN POLY PHARM (A)
GDS GDS HOLDINGS LTD. SPONSORED ADR CLASS A
603444 G-BITS NETWORK TECHNOLOGY (XIAMEN) CO. LTD. CLASS A
EVO EVOLUTION GAMING GROUP AB
603881 SHANGHAI ATHUB (A)
6669 WIWYNN CORP.
3933 UNITED LABORATORIES INTERNATIONAL HOLDINGS LTD.
1513 LIVZON PHARMACEUTICAL GROUP
01765 INC.
603605 HOPE EDUCATION GROUP (P CHIP)
FNV PROYA COSMETICS (A)
BIM FABRICA NACIONAL DE VIDRIOS C.A.
BIMOBJECT AB
- Yang Ku Kang
3Q17 review: investor appetite to grow further
Maintain BUY on a favorable regulatory turn in US regarding biosimilar reimbursement plan and the prospect of a robust increase in Truxima’s European sales in 4Q17. Raise target price to KRW90,000 as we adjust up our forecasts for each drug’s market share and growth rate.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.